RHI Magnesita Q2 FY27: consol. PAT +62% YoY to ₹62 Cr as margins expand, revenue flat
PAT +61.93% YoY · revenue -0.49% · margins expanding · inline vs street
₹1,030.29 Cr
-0.49% YoY
₹62.1 Cr
+61.93% YoY
5.98%
+2.3pp YoY
₹3.01
RHI Magnesita India's consolidated Q2 FY27 profit rose 61.9% year-on-year to ₹62.10 Cr (from ₹38.35 Cr in Q2 FY26) even as consolidated revenue was essentially flat at ₹1,030.29 Cr (-0.5% YoY) — this is a margin story, not a volume one. Sequentially PAT eased 3.9% from ₹64.61 Cr in Q1 FY27 even as revenue grew 1.6% QoQ, a seasonal wobble rather than a trend signal. Basic EPS was ₹3.01 versus ₹1.85 a year ago. The print landed about 2% light of our pre-result preview's ~₹1,050 Cr revenue expectation but within the previewed ₹55-65 Cr PAT band and the 13.0-13.5% targeted EBITDA margin range (actual OPM 13.22%); no independent external consensus report could be located to cross-check further, so the read leans on our own preview. Against management's FY27 guidance of a 13% full-year EBITDA margin (reaffirmed on the Q1 FY27 call), the quarter is on track to ahead — H1 FY27 OPM is running at 13.40%.
Q2 FY-2027 vs prior quarters
The margin expansion is a raw-material story: cost of materials consumed fell to 39.6% of consolidated revenue from 43.8% a year ago, outweighing a higher depreciation and finance-cost base; NPM improved to 5.98% from 3.70% YoY. There were no exceptional items this quarter in either statement (last year's FY26 annual numbers had carried a ₹556 Cr goodwill impairment, now out of the base). Standalone PAT of ₹70.97 Cr (+71.8% YoY) grew faster than consolidated, and standalone revenue rose 1.9% YoY against a 0.5% YoY decline at the group level — the gap points to a subsidiary/JV drag at the consolidated level that shouldn't be read through the standalone print alone. The quarter closed alongside CFO Azim Syed's resignation (effective 31 December 2026, succeeded by Abhishek Bajaj from 1 January 2027), the first limited review by new statutory auditor B S R & Co. LLP, and confirmation that both the Intermetal Engineers-Ashwath Technologies merger (effective 1 April 2026) and the 51%-owned RHI Khemka Minpro mineral-processing JV (incorporated 16 July 2026, now carrying a ₹10.5 Cr non-controlling interest) are live — resolving two of the three watch items flagged pre-result, alongside September's SBI Mutual Fund/Dalmia Bharat Refractories shareholding reshuffle. No management press release or concall commentary was available in this filing to independently corroborate the margin narrative.
The stock went into the print at ₹365.1, down 1.7% over the past month of trading.
EBITDA margin 13% for FY27 (unchanged). Volume growth 7-8% (clarified from 7-9% range). Capex ₹80-100 Cr annually. MINPRO JV: ₹35 Cr over 2 years, 8-10% EBITDA, <3yr payback.
— This quarter: met
W1
FY27 EBITDA margin guidance of 13% — H1 FY27 running at 13.40% (Q2 at 13.22%); watch Q3/Q4 as raw-material costs trend
W2
CFO transition completes 1 Jan 2027 (Bajaj succeeds Syed) — watch for continuity in reporting/strategy into Q3 FY27
W3
RHI Khemka Minpro JV (₹35 Cr total investment, management's 8-10% EBITDA / <3yr payback target) — track scale-up against that timeline
Clean, legible tables, unambiguous column headers (Sep-26/Jun-26/Sep-25/HY/FY-Mar-26). No exceptional items this quarter in either statement. Consolidated profit-for-period (₹62.10 Cr) splits into owners' share ₹62.14 Cr and NCI -₹0.47 Cr following first-time consolidation of 51%-owned RHI Khemka Minpro JV (from 16 Jul 2026). Figures converted from ₹ Lakh to ₹ Crore.
Margins and momentum: can Q2 extend the profit surge?
After 83% net profit growth in Q1, the Street watches whether refractories demand holds and EBITDA stays on the 13% full-year guidance. A new MD, large institutional inflows, and a depressed stock valuation frame a quarter where execution on pricing will matter more than volume.
What to expect: revenue steady, margins the key metric
RHI Magnesita's Q2 narrative hinges on whether EBITDA margin holds near 13% — the company's full-year guidance. In Q1 FY27, the company reported ₹1,014 Cr revenue (+5.6% YoY) and net profit of ₹64.6 Cr (+83% YoY), with EBITDA margin at 14.5%, 3.7 percentage points above prior year. For Q2, on-plan expectations are revenue in the ₹1,000–₹1,100 Cr range (modest single-digit growth), with the critical watch: can margins stay elevated, or do they normalize toward the 13% guidance?
~₹1,050 Cr
Q1 was ₹1,014 Cr; flat-to-modest growth on-plan
13.0%–13.5%
Management guidance post-Q1; Q1 delivered 14.5% (above guidance)
₹55–65 Cr
Q1 was ₹64.6 Cr; steady-state assumes no margin surprise
₹4.69k Cr
Analyst consensus; +16.6% YoY. Q1+Q2 tracking at ~₹2,064 Cr YTD
A strong print means revenue at or above ₹1,100 Cr with EBITDA margin at 14%+, signaling durable pricing power in refractories despite modest volume growth. A weak print is revenue below ₹950 Cr or margin compression below 12.5%, which would raise questions about demand softness or competitive pricing pressure and force a rethink of the full-year guidance.
On track: FY27 guidance and the trajectory
RHI Magnesita is tracking well to its full-year targets. Analyst consensus projects ₹4.69k Cr revenue for FY27 (+16.6% YoY) and EPS of ₹14.60 (+74% YoY). Q1 delivered 5.6% revenue growth and 83% net profit growth — the profit surge came primarily from margin expansion, not volume. If Q2 maintains the 13%+ EBITDA margin, the company will be on track for 15%–16% full-year margin, well above historical averages, assuming volumes stay steady. The key risk: if margins compress in Q2 back to 12–12.5%, it suggests the Q1 margin beat was cyclical rather than structural.
What the Street says
Since last quarter: governance shifts and institutional repositioning
1 · New MD and auditor in place
Pankaj Malhan (DIN 08516185) appointed MD & CEO (approved at AGM on Sep 29, 2026), replacing prior leadership. BSR & Co. LLP appointed as statutory auditor, replacing PwC. Both transitions are routine but mark the start of a new chapter — watch for strategic commentary in Q2 earnings call.
2 · Institutional ownership reshuffled
SBI Mutual Fund acquired 8.09% stake (16.72M shares at ₹360 in Sep 2026), replacing the exit of Dalmia Bharat Refractories (which sold its entire 13.08% stake). FII ownership slipped from 5.0% to 3.98% YoY, while DII rose to 14.35%. The large MF entry signals confidence in the recovery narrative.
3 · Subsidiary merger completed
Intermetal Engineers (India) subsidiary merged with Ashwath Technologies effective Aug 18, 2026. No material impact expected, but indicates housekeeping efforts. No pledges or regulatory flags reported.
The setup: what to watch on result day (Nov 13)
RHI Magnesita reports Q2 FY27 on November 13, 2026. The result will be dissected on three fronts: 1. Margin hold: Does EBITDA margin stay above 13% (in line with guidance), or does it slip? This is the swing factor — a margin beat repeats the Q1 momentum, a miss invites guidance review. 2. Volume and pricing balance: Revenue growth modest (5–10% expected), but pricing power will show in gross margin trend. Q2 typically sees seasonal demand from steel / cement sectors — watch commentary on order book and pricing realizations. 3. FY27 guidance reaffirm: Management is expected to reaffirm ₹4.69k Cr FY27 revenue and 13% margin guidance. Any tweak would signal a demand or competitive shift. New MD's tone on strategy and capital allocation will also be closely read.
RHI Magnesita India enters Q2 FY27 from a position of strength: 83% profit growth in Q1, margin expansion to 14.5%, analyst consensus at 100% Buy, and a new, credible management team. Yet the stock trades near 10-year lows and 60% off ATH, implying heavy skepticism on durability. The Street sees 45–55% upside if the company can prove margins are structural, not cyclical. Q2 is the test: if EBITDA margin holds at 13%+ and the company keeps guidance, the 44–55% bull thesis stands. A margin miss or guidance cut would punish both near-term and full-year sentiment. The Nov 13 result will be the moment the market reprices this recovery narrative.